Mechanisms of disease - Cancer stem cells

被引：1266

作者：

Jordan, Craig T.

Guzman, Monica L.

Noble, Mark

机构：

[1] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA

[2] Univ Rochester, Sch Med, Dept Biomed Genet, Rochester, NY 14642 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 12期

关键词：

D O I：

10.1056/NEJMra061808

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1253 / 1261

页数：9

共 84 条

[11]

Chiasson BJ, 1999, J NEUROSCI, V19, P4462

[12] Isolation and characterization of human mammary stem cells [J].

Clarke, RB .

CELL PROLIFERATION, 2005, 38 (06) :375-386

[13] A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia [J].

Cobaleda, C ;

Gutiérrez-Cianca, N ;

Pérez-Losada, J ;

Flores, T ;

García-Sanz, R ;

González, M ;

Sánchez-García, I .

BLOOD, 2000, 95 (03) :1007-1013

[14] Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction [J].

Copland, Mhairi ;

Hamilton, Ashley ;

EIrick, Lucy J. ;

Baird, Janet W. ;

Allan, Elaine K. ;

Jordanides, Niove ;

Barow, Martin ;

Mountford, Joanne C. ;

Holyoake, Tessa L. .

BLOOD, 2006, 107 (11) :4532-4539

[15] New targeted approaches in chronic myeloid leukemia (vol 23, pg 6316, 2005) [J].

Cortes .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :9034-9034

[16] New targeted approaches in chronic myeloid leukemia [J].

Cortes, J ;

Kantarjian, H .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6316-6324

[17] To the editor: Discontinuation of imatinib therapy after achieving a molecular response [J].

Cortes, J ;

O'Brien, S ;

Kantarjian, H .

BLOOD, 2004, 104 (07) :2204-2205

[18] Characterization of acute lymphoblastic leukemia progenitor cells [J].

Cox, CV ;

Evely, RS ;

Oakhill, A ;

Pamphilon, DH ;

Goulden, NJ ;

Blair, A .

BLOOD, 2004, 104 (09) :2919-2925

[19] Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors [J].

Cozzio, A ;

Passegué, E ;

Ayton, PM ;

Karsunky, H ;

Cleary, ML ;

Weissman, IL .

GENES & DEVELOPMENT, 2003, 17 (24) :3029-3035

[20] Tumour stem cells and drug resistance [J].

Dean, M ;

Fojo, T ;

Bates, S .

NATURE REVIEWS CANCER, 2005, 5 (04) :275-284

← 1 2 3 4 5 6 7 8 9 →